Skip to content

Clinical trials

Phase 3 trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Unknown status Country / region: China Clear all

970 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20043
20064
20079
200818
200914
201012
201130
201233
201349
201460
201576
201675
201769
201892
201999
202085
202196
202271
202359
202414

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status970

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University89
Fudan University40
Jiangsu HengRui Medicine Co., Ltd.33
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.30
Chinese Academy of Medical Sciences27
Peking Union Medical College Hospital13
Zhejiang Cancer Hospital13
Guangxi Medical University12
Second Affiliated Hospital, Zhejiang University, School of Medicine12
Beijing Friendship Hospital11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular53
Carcinoma, Non-Small-Cell Lung45
Stomach Neoplasms44
Colorectal Neoplasms38
Breast Neoplasms37
Nasopharyngeal Carcinoma33
Esophageal Neoplasms25
Lymphoma, Large B-Cell, Diffuse24
Diabetes Mellitus, Type 220
Uterine Cervical Neoplasms18

Trials

Showing 1 to 25 of 970. Each trial links to its page on Pharma Observatory.

870 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.